Patent classifications
A61G10/02
PORTABLE ISOLATION UNIT
A portable isolation unit for use with a bed or chair, including an enclosure portion configurable between a stowed state and a deployed state, in which the enclosure portion substantially shields over an end of the bed or chair; a ventilation unit configured for applying air pressure to an area beneath the enclosure portion when the enclosure portion is in the deployed state; and a portable frame to which the enclosure portion and ventilation unit are mounted.
HERMETIC TARPAULIN DEVICE AND NURSING ROOM
Disclosed are a hermetic tarpaulin device and a nursing room. The hermetic tarpaulin device includes a frame and a tarpaulin body. The frame can be unfolded or folded into a predetermined shape. The tarpaulin body can be connected to the frame. When the frame is unfolded, the tarpaulin body is unfolded to form a hermetic space completely isolated from an outside world, and when the frame is folded, the tarpaulin body is folded into a whole. The tarpaulin body can be unfolded with the frame to form a hermetic space completely isolated from the outside world, which can achieve complete isolation from the outside world, thereby improving the isolation effect, and the nursing room can be more convenient to build, and can also reduce the cost and reduce the occupied space.
AIRWAY MANAGEMENT ISOLATION CHAMBER
An airway management isolation enclosure and a method for protecting medical personnel from infectious agents when treating a patient having an infectious disease, comprising: (a) a frame that is positioned over the head and anterior thoracic region of the patient; (b) a transparent barrier supported by frame, which covers and forms a seal around the head and anterior thoracic region of the patient and allows medical personnel to create sealable entry ports; and (c) an air flow entry and a vacuum exit connection to direct the infectious agents in the form of respiratory droplets and particles produced by the patient to flow away from the head of the patient and out of the transparent covering while the medical personnel manages the airway and upper aerodigestive tract of the patient.
Individual Biocontainment Unit to Reduce Infectious or Communicable Disease Transmission to Healthcare Workers, Bystanders, and Patients
A biocontainment assembly for use with a patient suspected of having or diagnosed with a transmissible disease(s) capable of respiratory, airborne, contact, or droplet transmission includes a housing configured to be positioned over and at least partially enclose a head, neck, and/or torso of the patient. A sidewall of the housing includes an open portion contiguous with an at least partially pen bottom portion of the housing, sized to fit over at least a portion of the head, neck, and/or a torso of the patient. The housing also includes an airflow opening for evacuating fluid from an interior defined by the housing. The assembly also includes a drape configured to extend across the open portion of the sidewall having a first portion removably connected to the housing and an opposing second portion configured to be draped over the torso, abdomen, waist, and/or legs of the patient.
Individual Biocontainment Unit to Reduce Infectious or Communicable Disease Transmission to Healthcare Workers, Bystanders, and Patients
A biocontainment assembly for use with a patient suspected of having or diagnosed with a transmissible disease(s) capable of respiratory, airborne, contact, or droplet transmission includes a housing configured to be positioned over and at least partially enclose a head, neck, and/or torso of the patient. A sidewall of the housing includes an open portion contiguous with an at least partially pen bottom portion of the housing, sized to fit over at least a portion of the head, neck, and/or a torso of the patient. The housing also includes an airflow opening for evacuating fluid from an interior defined by the housing. The assembly also includes a drape configured to extend across the open portion of the sidewall having a first portion removably connected to the housing and an opposing second portion configured to be draped over the torso, abdomen, waist, and/or legs of the patient.
Hyperbaric oxygen chamber manufactured utilizing additive manufacturing
The present invention relates to an adaptive hyperbaric oxygen chamber designed to function as a medical apparatus in order to treat a subject suffering from any FDA approved medical condition. The hyperbaric oxygen chamber is designed and constructed in such a way that only one subject can be allowed to sit in an upright seated position, unless the pediatric seat is occupied by a pediatric patient and the adult is seated in the standard seat to accompany the pediatric patient. The upright patient seat when treating a pediatric patient is in the extended position while the occupant enters and exits the mono medical hyperbaric oxygen chamber and the seat is returned to the fixed position inside the hyperbaric oxygen chamber while the overhead door is closed, the seat being operated by an extension device. The hyperbaric oxygen chamber is made, using additive manufacturing technology. The hyperbaric oxygen chamber provides two hundred to five hundred liters of one hundred percent oxygen per minute to the pressure vessel. A nitrogen scrubber is connected to a discharge air duct of this hyperbaric oxygen chamber that converts the oxygen being expelled through the air duct to one hundred percent nitrogen.
VERTICAL SOFT U-SHAPED OPENING AND CLOSING SEALED AIR-PRESSURE CHAMBER
The present invention discloses a vertical soft U-shaped opening and closing sealed air-pressure chamber, comprising a chamber body and an outer zipper strip. The outer zipper strip is a U-shaped structure and installed in a front-end surface of a chamber door. A U-shaped sealing strip is arranged in a middle position between an inner zipper slider and an outer zipper slider. The chamber body is sealed in a U-shaped way, which can be adapted to various soft air pressure chambers. Whether a human body or the human body carried in a wheelchair or a cart is very convenient to enter the chamber body.
VERTICAL SOFT U-SHAPED OPENING AND CLOSING SEALED AIR-PRESSURE CHAMBER
The present invention discloses a vertical soft U-shaped opening and closing sealed air-pressure chamber, comprising a chamber body and an outer zipper strip. The outer zipper strip is a U-shaped structure and installed in a front-end surface of a chamber door. A U-shaped sealing strip is arranged in a middle position between an inner zipper slider and an outer zipper slider. The chamber body is sealed in a U-shaped way, which can be adapted to various soft air pressure chambers. Whether a human body or the human body carried in a wheelchair or a cart is very convenient to enter the chamber body.
MOBILE ISOLATION WARD
Disclosed herein is a mobile isolation ward including: a main body configured such that a door is installed in a front thereof, a fixed lighting window is installed in a right side thereof, and a light is installed at the center of a ceiling thereof; a ceiling air conditioner installed in the right side of the ceiling of the main body, and configured to control the temperature and the humidity inside the main body; an air purifier provided on one side of the inside of the main body, and configured to purify contaminated air inside the main body via a filter; and a blower configured to selectively introduce and discharge air. The junctions of the lighting window and the main body are finished with silicone. The main body is made of a glass fiber reinforced plastic material. The door and the lighting window are made of a transparent acrylic material.
Modulation of Amyloid Beta Toxicity and Processing By Xenon Gas
Disclosed are the unique and unexpected findings that xenon gas possesses the ability to directly inhibited amyloid beta associated toxicity, inhibit production of amyloid beta, and stimulate synthesis of soluble, free-form amyloid beta. The invention teaches the use of xenon gas, as well as various combinations of Noble Gases, for the prevention, amelioration, and treatment of Alzheimer's Disease and other pathologies associated with generation of insoluble aggregates containing amyloid beta.